Effectiveness and Safety of Generic Delayed-Release Dimethyl Fumarate (Sclera ® or Marovarex ®, Hikma) in Routine Medical Practice in the Treatment of Relapsing-Remitting Multiple Sclerosis in MENA Region

Condition:   Relapsing Remitting Multiple Sclerosis Intervention:   Drug: Dimethyl Fumarate (DMF) Sponsor:   Hikma Pharmaceuticals LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials